Literature DB >> 20459361

Liposomes as delivery systems for nasal vaccination: strategies and outcomes.

Béatrice Heurtault1, Benoît Frisch, Françoise Pons.   

Abstract

IMPORTANCE OF THE FIELD: Among the particulate systems that have been envisaged in vaccine delivery, liposomes are very attractive. These phospholipid vesicles can indeed deliver a wide range of molecules. They have been shown to enhance considerably the immunogenicity of weak protein antigens or synthetic peptides. Also, they offer a wide range of pharmaceutical options for the design of vaccines. In the past decade, the nasal mucosa has emerged as an effective route for vaccine delivery, together with the opportunity to develop non-invasive approaches in vaccination. AREAS COVERED IN THIS REVIEW: This review focuses on the recent strategies and outcomes that have been developed around the use of liposomes in nasal vaccination. WHAT THE READER WILL GAIN: The various formulation parameters, including lipid composition, size, charge and mucoadhesiveness, that have been investigated in the design of liposomal vaccine candidates dedicated to nasal vaccination are outlined. Also, an overview of the immunological and protective responses obtained with the developed formulations is presented. TAKE HOME MESSAGE: This review illustrates the high potential of liposomes as nasal vaccine delivery systems.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20459361     DOI: 10.1517/17425247.2010.488687

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  12 in total

Review 1.  Current prospects and future challenges for nasal vaccine delivery.

Authors:  Helmy Yusuf; Vicky Kett
Journal:  Hum Vaccin Immunother       Date:  2016-12-09       Impact factor: 3.452

2.  Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.

Authors:  Angela Henderson; Katie Propst; Ross Kedl; Steven Dow
Journal:  Vaccine       Date:  2011-05-19       Impact factor: 3.641

3.  Small Wonders-The Use of Nanoparticles for Delivering Antigen.

Authors:  Aya Taki; Peter Smooker
Journal:  Vaccines (Basel)       Date:  2015-08-10

4.  Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.

Authors:  Chenchen Bi; Aiping Wang; Yongchao Chu; Sha Liu; Hongjie Mu; Wanhui Liu; Zimei Wu; Kaoxiang Sun; Youxin Li
Journal:  Int J Nanomedicine       Date:  2016-12-07

Review 5.  Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.

Authors:  Blaise Corthésy; Gilles Bioley
Journal:  Front Immunol       Date:  2018-03-07       Impact factor: 7.561

Review 6.  Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials.

Authors:  Veena Vijayan; Adityanarayan Mohapatra; Saji Uthaman; In-Kyu Park
Journal:  Pharmaceutics       Date:  2019-10-14       Impact factor: 6.321

Review 7.  Vaccine delivery using nanoparticles.

Authors:  Anthony E Gregory; Richard Titball; Diane Williamson
Journal:  Front Cell Infect Microbiol       Date:  2013-03-25       Impact factor: 5.293

8.  Strategies for intranasal delivery of vaccines.

Authors:  Mehfuz Zaman; Saranya Chandrudu; Istvan Toth
Journal:  Drug Deliv Transl Res       Date:  2012-07-12       Impact factor: 4.617

9.  Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection.

Authors:  Asher Maroof; Yvonne M Yorgensen; Yufeng Li; Jay T Evans
Journal:  PLoS Pathog       Date:  2014-01-23       Impact factor: 6.823

Review 10.  Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation.

Authors:  Saborni Chattopadhyay; Jui-Yi Chen; Hui-Wen Chen; Che-Ming Jack Hu
Journal:  Nanotheranostics       Date:  2017-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.